In the TCGA data, we found that patients with downregulation of RB1 along with downregulation of any of these six genes had better survival compared to patients with downregulation of RB1 alone (Fig 3D); the same trend was observed for the 12 genes identified in any one of human cancer cell lines screens (S9A Fig). This evidence concerns the gene RB1 and cancer.